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In Brief
 
Wnt Inhibits Apoptosis
 
The protooncogene Wnt-1 is a secreted
glycoprotein capable of both acting as a
growth factor and modulating gene
transcription and thus cell fate. Its link
to tumorigenesis has been assumed to
involve either or both of these func-
tions. But on page 87, Chen et al. re-
port that Wnt-1 can increase cell sur-
vival by reducing apoptosis in response
to chemotherapeutic drugs.
Chen et al. find that cells producing
Wnt-1 show less than half the amount
of apoptotic death seen in wild-type
cells in response to treatment with
the antimicrotubule chemotherapeu-
tic drugs vincristine and vinblastine.
Wnt-1 signaling normally inhibits the
constitutive phosphorylation and deg-
 
radation of 
 
b
 
-catenin, allowing the
 
b
 
-catenin to enter the nucleus and ac-
tivate gene expression by interaction
with members of the Lef/Tcf family of
transcription factors. In the current
paper, full levels of apoptosis are re-
stored in the presence of a dominant-
negative Tcf, but various other signal-
ing pathways that are stress-induced
or potentially apoptosis-inhibiting are
not affected by Wnt-1 expression.
Candidate downstream targets of
Lef/Tcf that would affect apoptosis,
such as Fas, Bcl, and IAP proteins,
are not turned on by Wnt-1 expres-
sion. Identifying the relevant Lef/Tcf
target or targets is crucial. But just as
important will be coming up with
drugs to inhibit the Lef/Tcf pathway.
Such drugs should eliminate the ap-
optosis-resistance of tumor cells that
have abnormally activated Wnt sig-
 
naling, and thus improve the effec-
tiveness of existing chemotherapies.
 
Esp1p Triggers both Phases
of Anaphase
 
Anaphase is initiated in yeast when the
anaphase-promoting complex (APC)
targets Pds1p for destruction, thus free-
ing up Pds1p’s binding partner  Esp1p
so that it can cleave the cohesin protein
Scc1p. This relieves sister-chromatid
cohesion, and the chromosome separa-
tion of anaphase A can proceed.
Anaphase B, the lengthening of the
spindle, could also result directly from
this release of cohesive tension. But
on page 27, Jensen et al. report that
Esp1p is required even in the absence
of sister cohesion, for some function
that induces spindle elongation. Yeast
lacking both Scc1p and Esp1p func-
tion show premature sister separa-
tion (because Scc1p is lacking), but
the spindle does not elongate (be-
cause Esp1p is lacking).
Jensen et al. find that Esp1p moves
from the chromatin to the spindle
around the time of the metaphase to
anaphase transition. Pds1p is needed
for both the nuclear and, indepen-
dently, spindle localization of Esp1p,
although the viability of a strain lacking
all Pds1p suggests that some Esp1p can
function without the help of Pds1p.
The movement of Esp1p from chroma-
tin to spindle may also be related to an
APC-induced proteolysis event.
Much of the spindle-localized
Esp1p is at the midzone, where micro-
tubules from opposite poles interdigi-
tate. Motors acting on these inter-
digitating microtubules may drive
spindle-lengthening during anaphase
B, and Esp1p may regulate this pro-
cess. The first experiment will be to
test whether Esp1p’s protease activity
is necessary for its spindle function. If
 
so, the search for Esp1p’s spindle sub-
strate will be on.
 
Calreticulin and a Termination 
Factor in Nuclear Export
 
Two papers in this issue add to our
understanding of nuclear export. Ho-
laska et al. find that calreticulin, a
chaperone previously reported to
function in the endoplasmic reticulum
(ER), also acts in the nucleoplasm as
a nuclear export receptor for steroid
 
hormone receptors (page 127). Black
et al. look at a later step in the export
pathway in their report on NXT1,
which they propose is involved in de-
livering export complexes to a site
on the cytoplasmic side of the nu-
clear pore complex (NPC) where re-
ceptor and substrate can be released
(page 141).
Holaska et al. study export of a
model substrate, protein kinase inhib-
itor (PKI), from nuclei of permeabi-
lized cells. Export continues in the ab-
sence of the general export receptor,
Crm1, and purification of the remain-
ing activity yields calreticulin. Ho-
laska et al. speculate that calreticulin
may be retrotranslocated out of the
ER, as are certain bacterial toxins.
Calreticulin has a 400-fold higher af-
finity for nuclear export signals than
for the folding intermediates that it
encounters in the ER.
Calreticulin is known to block the
binding of several nuclear hormone re-
ceptors to DNA, and Holaska et al.
find that calreticulin (but not Crm1)
can promote nuclear export of the glu-
cocorticoid receptor (GR). The in vivo
export of GR absolutely requires cal-
reticulin. (This is an interesting twist 
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on GR nuclear import, which requires
Hsp90 binding to GR to induce a con-
formation capable of drug binding and
thus nuclear entry.) The DNA-binding
domain of GR acts as a calreticulin-
dependent nuclear export signal.
At limiting concentrations of ei-
ther Crm1 or calreticulin, export is
dependent on the GTP-bound form
of the GTPase Ran. In the cyto-
plasm, hydrolysis of GTP to yield
RanGDP is thought to liberate trans-
ported proteins.
Black et al. suggest that NXT1 may
transport export complexes to a site
where this hydrolysis can occur. They
find that Crm1 and RanGTP cooper-
ate to export protein to a NPC site
that is accessible to cytoplasmic anti-
bodies. NXT1 added at this stage has
no effect, but NXT1 included from
the start of the export reaction leads
to displacement of the complex from
the NPC. NXT1 does not enhance the
binding of Crm1 to the nuclear export
substrate, or of RanGTP to Crm1, so
Black et al. suggest that it is function-
ing at a later stage to deliver the com-
plex to a site where RanBP1 can act
to expose RanGTP to the actions of
cytoplasmic RanGAP. The resulting
 
GTP hydrolysis should free both re-
ceptor and substrate. This theory may
be strengthened by future electron
microscopy to localize the proteins
acting at different stages.
 
Proteomics for Phagosomes
 
On page 165, Garin et al. identify 140
proteins from phagosomes, adding to
an earlier proteomics description in
 
The Journal
 
 of the nuclear pore com-
plex (Rout et al., 148:635–652). These
focused proteomics efforts allow the
identification of low abundance pro-
teins, and simultaneously give protein
localization information.
Confidence in the proteins’ local-
ization is high in this case because the
 
phagosomes were formed after en-
gulfment of latex beads, which allow
the phagosomes to be purified well
away from any contaminating or-
ganelles. Some proteins known to be
associated with other organelles are,
however, amongst those identified.
Contamination is not a likely explana-
tion because the most abundant pro-
teins in these other organelles are not
present in the phagosome sample.
Garin et al. suggest other explana-
tions. Proteins from the ER, for ex-
ample, may arrive at the phagosome
when ER membranes are used for
membrane homeostasis. Phagosome
membranes returning to the plasma
membrane may be replenished using
ER membranes.
The lipid raft protein flotillin-1 is
another surprise. Although it could
just be coming along for the ride dur-
ing phagocytosis, an increase in its
abundance during phagosome matu-
ration suggests that lipid rafts and
membrane specialization may have a
role in phagosome function. The
abundance of different hydrolases
also varies during phagosome matura-
tion, suggesting a sequential matura-
tion process.
The 140 proteins include a number
of apoptosis-related proteins. The cell
may monitor the state of affairs inside
the phagosome, and induce apoptosis
of the phagocytic cell if the phagocy-
tosed organism is not being brought
under control. This proposed apopto-
sis control is just one of the new as-
pects of phagosome biology revealed
by this study.
 
By William A. Wells, 1012 Sanchez Street, San
Francisco, CA 94114. E-mail: wells@biotext.com